Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

RefinitivMenos de 1 minuto de lectura

Intellia Therapeutics Inc NTLA:

INTELLIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Inicie sesión o cree una cuenta gratuita y permanente para leer esta noticia